Context Therapeutics (CNTX) Shares Issued (2024 - 2025)

Context Therapeutics' (CNTX) quarterly Shares Issued came in at $15268.0 in Q2 2025, up 200.0% quarter-over-quarter from -$15268.0 in Q1 2025.

Context Therapeutics (CNTX) Shares Issued (2024 - 2025) Analysis & Trends

Context Therapeutics has disclosed Shares Issued across 2 years of filings, most recently posting $15268.0 for Q2 2025.

Shares Issued for Q2 2025 came in at $15268.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $15268.0 (up 100.02% YoY), and the FY2024 annual result was $14.5 million, changed N/A from the prior year.
Shares Issued came in at $15268.0 for Q2 2025 at Context Therapeutics, up from -$15268.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $15268.0 in Q2 2025 to a low of -$80.2 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	5.40 Mn
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	27.00 Mn
9	Abivax	94.26 Bn	94.26 Bn	-	26,927.15
10	Context Therapeutics	166.57 Mn	166.57 Mn	-	-

Download Data